These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37103915)

  • 1. The Efficacy of Lumateperone in Patients With Bipolar Depression With Mixed Features.
    McIntyre RS; Durgam S; Huo J; Kozauer SG; Stahl SM
    J Clin Psychiatry; 2023 Apr; 84(3):. PubMed ID: 37103915
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjunctive lumateperone (ITI-007) in the treatment of bipolar depression: Results from a randomized placebo-controlled clinical trial.
    Suppes T; Durgam S; Kozauer SG; Chen R; Lakkis HD; Davis RE; Satlin A; Vanover KE; Mates S; McIntyre RS; Tohen M
    Bipolar Disord; 2023 Sep; 25(6):478-488. PubMed ID: 36779257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Lumateperone for Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder: A Phase 3 Randomized Placebo-Controlled Trial.
    Calabrese JR; Durgam S; Satlin A; Vanover KE; Davis RE; Chen R; Kozauer SG; Mates S; Sachs GS
    Am J Psychiatry; 2021 Dec; 178(12):1098-1106. PubMed ID: 34551584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cariprazine for the treatment of bipolar mania with mixed features: A post hoc pooled analysis of 3 trials.
    McIntyre RS; Masand PS; Earley W; Patel M
    J Affect Disord; 2019 Oct; 257():600-606. PubMed ID: 31344528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of lumateperone on symptoms of depression in bipolar I and bipolar II disorder: Secondary and post hoc analyses.
    McIntyre RS; Durgam S; Kozauer SG; Chen R; Huo J; Davis RE; Cutler AJ
    Eur Neuropsychopharmacol; 2023 Mar; 68():78-88. PubMed ID: 36640735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lurasidone in the treatment of bipolar depression with mixed (subsyndromal hypomanic) features: post hoc analysis of a randomized placebo-controlled trial.
    McIntyre RS; Cucchiaro J; Pikalov A; Kroger H; Loebel A
    J Clin Psychiatry; 2015 Apr; 76(4):398-405. PubMed ID: 25844756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.
    Cutler AJ; Datto C; Nordenhem A; Minkwitz M; Acevedo L; Darko D
    Clin Ther; 2011 Nov; 33(11):1643-58. PubMed ID: 22054797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.
    van der Loos ML; Mulder PG; Hartong EG; Blom MB; Vergouwen AC; de Keyzer HJ; Notten PJ; Luteijn ML; Timmermans MA; Vieta E; Nolen WA;
    J Clin Psychiatry; 2009 Feb; 70(2):223-31. PubMed ID: 19200421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of cariprazine in bipolar I depression: A double-blind, placebo-controlled phase 3 study.
    Earley WR; Burgess MV; Khan B; Rekeda L; Suppes T; Tohen M; Calabrese JR
    Bipolar Disord; 2020 Jun; 22(4):372-384. PubMed ID: 31628698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Lumateperone for Treatment of Schizophrenia: A Randomized Clinical Trial.
    Correll CU; Davis RE; Weingart M; Saillard J; O'Gorman C; Kane JM; Lieberman JA; Tamminga CA; Mates S; Vanover KE
    JAMA Psychiatry; 2020 Apr; 77(4):349-358. PubMed ID: 31913424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lurasidone in Children and Adolescents with Bipolar Depression Presenting with Mixed (Subsyndromal Hypomanic) Features:
    Singh MK; Pikalov A; Siu C; Tocco M; Loebel A
    J Child Adolesc Psychopharmacol; 2020 Dec; 30(10):590-598. PubMed ID: 32392455
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety and efficacy of aripiprazole 2-month ready-to-use 960 mg: secondary analysis of outcomes in adult patients with bipolar I disorder in a randomized, open-label, parallel-arm, pivotal study.
    McIntyre RS; Such P; Yildirim M; Madera-McDonough J; Zhang Z; Larsen F; Harlin M
    Curr Med Res Opin; 2023 Jul; 39(7):1021-1030. PubMed ID: 37272079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial.
    Niufan G; Tohen M; Qiuqing A; Fude Y; Pope E; McElroy H; Ming L; Gaohua W; Xinbao Z; Huichun L; Liang S
    J Affect Disord; 2008 Jan; 105(1-3):101-8. PubMed ID: 17531327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Japanese subpopulation analysis of a randomized, double-blind, placebo-controlled study.
    Katagiri H; Tohen M; McDonnell DP; Fujikoshi S; Case M; Kanba S; Takahashi M; Gomez JC
    BMC Psychiatry; 2013 May; 13():138. PubMed ID: 23672672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
    Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
    J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zonisamide for bipolar disorder, mania or mixed states: a randomized, double blind, placebo-controlled adjunctive trial.
    Dauphinais D; Knable M; Rosenthal J; Polanski M; Rosenthal N
    Psychopharmacol Bull; 2011; 44(1):5-17. PubMed ID: 22506436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjunctive long-acting risperidone in patients with bipolar disorder who relapse frequently and have active mood symptoms.
    Macfadden W; Adler CM; Turkoz I; Haskins JT; Turner N; Alphs L
    BMC Psychiatry; 2011 Oct; 11():171. PubMed ID: 22034906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of low- and high-dose cariprazine in acute and mixed mania associated with bipolar I disorder: a double-blind, placebo-controlled study.
    Calabrese JR; Keck PE; Starace A; Lu K; Ruth A; Laszlovszky I; Németh G; Durgam S
    J Clin Psychiatry; 2015 Mar; 76(3):284-92. PubMed ID: 25562205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of asenapine on depressive symptoms in patients with bipolar I disorder experiencing acute manic or mixed episodes: a post hoc analysis of two 3-week clinical trials.
    Szegedi A; Zhao J; van Willigenburg A; Nations KR; Mackle M; Panagides J
    BMC Psychiatry; 2011 Jun; 11():101. PubMed ID: 21689438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olanzapine versus risperidone in the treatment of manic or mixed States in bipolar I disorder: a randomized, double-blind trial.
    Perlis RH; Baker RW; Zarate CA; Brown EB; Schuh LM; Jamal HH; Tohen M
    J Clin Psychiatry; 2006 Nov; 67(11):1747-53. PubMed ID: 17196055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.